International
Pharmatech Oncology has developed strategic collaborations with sites in Hong Kong and Eastern Europe. Through these relationships, we can significantly increase the number of potential study subjects, especially in smaller indications or non-standard-of-care treatment options in the US. Sponsors can select to work with these sites directly, or have Pharmatech Oncology manage the international component of your studies.
Press Release from Tamir Biotechnologies
7/6/2010
Pharmatech Oncology's Presentation at 46th Annual DIA Meeting
6/25/2010
Pharmatech Oncology to Present at 46th Annual DIA Meeting
6/10/2010
Pharmatech Oncology Announces ASCO Abstracts
5/17/2010
Pharmatech Oncology Launches New Data Management Business Unit
4/23/2009
